General Information of the Compound
| Compound ID |
CP0237842
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5,7-Dimethyl-2-methylamino-4-pyridin-3-ylmethyl-benzothiazol-6-ol
Show/Hide
|
||||||||||||||||||
| Synonyms |
145096-30-6
5,7-Dimethyl-2-(methylamino)-4-(3-pyridinylmethyl)-6-benzothiazolol
5,7-Dimethyl-2-methylamino-4-pyridin-3-ylmethyl-benzothiazol-6-ol
6-Benzothiazolol, 5,7-dimethyl-2-(methylamino)-4-(3-pyridinylmethyl)-
6-Hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole
6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole
AC1L9EDQ
BDBM50037037
C11593
CHEBI:271098
CHEBI:4732
CHEMBL105139
DTXSID80162877
E 3040
E-3040
E3040
L001447
SCHEMBL6009376
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H17N3OS
|
||||||||||||||||||
| Molecular Weight |
299.399
|
||||||||||||||||||
| Canonical SMILES |
CNc1nc2c(Cc3cccnc3)c(C)c(O)c(C)c2s1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H17N3OS/c1-9-12(7-11-5-4-6-18-8-11)13-15(10(2)14(9)20)21-16(17-3)19-13/h4-6,8,20H,7H2,1-3H3,(H,17,19)
Show/Hide
|
||||||||||||||||||
| InChIKey |
IONAQTGMWFXHIX-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
145096-30-6
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Clinical Information about the Compound